| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:320.)
© 2006 American Heart Association, Inc.
Advances in Stroke 2005 |
From the Stroke Prevention Research Unit (P.M.R.), University of Oxford, Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK; and the Department of Neurology (S.C.J.), University of California, San Francisco, Calif.
Correspondence to Peter M. Rothwell, Professor of Clinical Neurology, Stroke Prevention Research Unit, University Department of Clinical Neurology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE. E-mail peter.rothwell@clneuro.ox.ac.uk
Key Words: cerebral ischemia, transient
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
In recent years, it has become clear that the risk of stroke after a transient ischemic attack (TIA) or minor ischemic stroke is higher than was previously supposed, with consistent reports of 7-day stroke risks of up to 10%,14 and other evidence of the very short time-window for prevention of stroke after a TIA.5 However, patients with TIA and minor stroke are a highly heterogeneous group in terms of symptoms, risk factors and underlying pathology, and the early risk of recurrent stroke is likely to vary between different clinical and etiological subtypes. In order to appropriately target secondary prevention, we therefore need reliable data on risk in particular subgroups and ideally in individuals. Recent studies have provided some useful data, although many important issues are still unresolved.
There is good evidence that the presenting clinical features of a TIA provide considerable prognostic information. Johnston and colleagues identified 5 risk factors independently associated with a higher 3-month risk of recurrent stroke in a large emergency departmentbased TIA cohort: age >60 years (OR=1.8; 95% CI, 1.4 to 2.9), symptom duration >10 minutes (2.3, 1.3 to 4.2), weakness (1.9, 1.4 to 2.6), speech impairment (1.5, 1.1 to 2.1), and diabetes mellitus (2.1, 1.1 to 2.7).1 A simple index with 1 point for each risk factor was useful in estimating risk at 3 months, which varied from 0% in patients with no risk factors to 34% in those with 5 risk factors, and also differentiated between risk groups during the first few days after
This article has been cited by other articles:
![]() |
B. Ovbiagele, S. Cruz-Flores, M. J. Lynn, M. I. Chimowitz, and for the Warfarin-Aspirin Symptomatic Intracranial Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis Arch Neurol, June 1, 2008; 65(6): 733 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ois, M. Gomis, A. Rodriguez-Campello, E. Cuadrado-Godia, J. Jimenez-Conde, C. Pont-Sunyer, G. Cuccurella, and J. Roquer Factors Associated With a High Risk of Recurrence in Patients With Transient Ischemic Attack or Minor Stroke Stroke, June 1, 2008; 39(6): 1717 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge Response to Letter by Tang et al Stroke, December 1, 2007; 38(12): e158 - e159. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |